It says, “Serum Institute of India, would like to clarify that the current claims surrounding COVISHIELD’s availability in the media are completely false and conjectural. Presently, the government has granted us permission to only manufacture the vaccine and stockpile it for future use.

COVISHIELD will be commercialized once the trials are proven successful and all the requisite regulatory approvals are in place. The phase-3 trials for the Oxford-AstraZeneca vaccine are still underway. And only once the vaccine is proven immunogenic and efficacious, SII will confirm its availability, officially”.

Serum Institute of India  wants everyone to know that any quotes, statements from any officials or spokesperson of Serum Institute of India other than Mr. Adar Poonawalla will not be official.